Smith & Nephew PLC ORD USD0.20
Smith & Nephew PLC ORD USD0.20/ GB0009223206 /
SN/
2024-08-16 9:00:00 PM
|
Chg.
-2.0000
|
Volume |
Bid2024-08-16 |
Ask2024-08-16 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
1,168.5000GBX
|
-0.17%
|
1.03 mill. Turnover(GBP): 12.04 mill. |
930.0000Bid Size: 4,575 |
1,390.0000Ask Size: 1,618 |
10.22 bill.GBP |
- |
- |
Business description
Smith & Nephew plc is a global medical technology business. The company has two reportable business segments: Advanced Surgical Devices (Orthopaedic Reconstruction, Trauma & Extremities, Sports Medicine and Arthroscopy Enabling Technologies) and Advanced Wound Management. Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. The company has distribution channels, purchasing agents and buying entities in over 100 countries worldwide. Smith & Nephew plc is headquartered in London, UK.
Management board & Supervisory board
CEO |
Deepak Nath |
Management board |
John Rogers, Brad Cannon, Paul Connolly, Phil Cowdy, Myra Eskes, Mizanu Kebede, Elga Lohler, Vasant Padmanabhan, Alison Parkes, Helen Barraclough, Scott Schaffner |
Supervisory board |
Roberto Quarta, Rupert Soames, Deepak Nath, Marc Owen, Jo Hallas, John Ma, Angie Risley, Bob White, Katarzyna Mazur-Hofsaess, Rick Medlock, John Rogers |
Company data
Name: |
Smith & Nephew plc |
Address: |
Building 5, Croxley Park Hatters Lane Watford,Hertfordshire WD18 8YE UK |
Phone: |
+44-1923-477-100 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.smith-nephew.com/ |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
Advanced Medical Devices |
End of financial year: |
12-31 |
Free Float: |
- |
IPO date: |
- |